论文部分内容阅读
用ｒＩＬ２和自体外周血克隆化ＬＡＫ细胞体外二步净化白血病骨髓后行ＡＢＭＴ，移植后体内再用ｒＩＬ２／ＬＡＫ细胞治疗；４例行ＡＢＭＴ白血病病人用ｒＩＬ２／ＬＡＭ细胞体内外净化后，２例对化疗无效的病人（淋巴瘤性白血病与慢性各１例）获ＣＴ，４例病人移植后至１９９４年９月持续缓解８～１４月，移植后第３周末测定外周血ＮＫ细胞活性明显高于另３例未净化行ＡＢＭＴ白血病病人；ｒＩＬ２／ＬＡＫ细胞体外二步净化骨髓不影响ＣＦＵ－ＧＭ回收率，移植后不影响造血功能重建。
ABMT was performed in two steps in vitro to purify leukemia bone marrow with rIL2 and autologous peripheral blood. After transplantation, rIL2 / LAK cells were treated with rIL2 / LAK cells in vivo. In 4 patients with ABMT leukemia, rIL2 / LAM cells were purified in vivo and in vitro, Chemotherapy invalid patients (1 cases of lymphoma leukemia and chronic) were CT, 4 patients after transplantation to September 1994 continued to ease 8 to 14 months after transplantation the third weekend measured peripheral blood NK cell activity was significantly higher than the other Three cases of untreated ABMT leukemia patients; rIL2 / LAK cells two-step in vitro purification of bone marrow does not affect the CFU-GM recovery after transplantation does not affect the reconstruction of hematopoietic function.